
结核分枝杆菌二线抗结核药物耐药分子机制研究进展
Progress on molecular mechanism of drug resistance of second-line antituberculosis agents in Mycobacterium tuberculosis
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |